Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
- Conditions
- Multi-resistant Enterobacteriaceae ColonisationNosocomial OutbreaksPregnancy
- Registration Number
- NCT02631226
- Lead Sponsor
- Corporacion Parc Tauli
- Brief Summary
The purpose of this study is to determine the prevalence and risk factors for multi-resistant enterobacteriaceae colonization in less than 32 weeks pregnant women admitted to the hospital and its transmission to the newborn, in order to avoid neonatal intensive care unit spread and nosocomial outbreaks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 580
Inclusion Criteria
- Less than 32 weeks pregnant woman
- Admitted to the hospital
Exclusion Criteria
- Screening done after 48 hours of admission
- When delivery occurs before screening is performed
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of multi-resistant enterobacteriaceae colonisation in less than 32 weeks pregnant women 18 months
- Secondary Outcome Measures
Name Time Method Incidence of multi-resistant enterobacteriaceae colonisation of pregnant women admitted to the hospital by preterm premature rupture of membranes (PPROM) 18 months Transmission rate from the colonized woman to the newborn 18 months Prevalence of multi-resistant enterobacteriaceae colonisation of African or Asian pregnant women 18 months Number of multi-resisitant enterobacteriacea sepsis in the Neonatal Unit 18 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of multi-resistant Enterobacteriaceae colonization in preterm pregnant women?
How does the EME study compare to standard-of-care strategies for preventing nosocomial outbreaks in neonatal ICUs?
Which biomarkers are associated with increased risk of multi-resistant Enterobacteriaceae transmission from mothers to newborns?
What are the potential adverse events linked to multi-resistant Enterobacteriaceae colonization during pregnancy and neonatal care?
Are there effective combination therapies or alternative approaches to managing multi-resistant Enterobacteriaceae in hospitalized preterm pregnancies?
Trial Locations
- Locations (1)
Hospital de Sabadell. Corporacio Sanitaria Parc Tauli
🇪🇸Sabadell, Barcelona, Spain
Hospital de Sabadell. Corporacio Sanitaria Parc Tauli🇪🇸Sabadell, Barcelona, SpainVictoria AldecoaContact